Anti-obesity drug development-Reference-Cited by-同舟云学术

Anti-obesity drug development

Published:2002-09 Issue:9 Volume:11 Page:1189-1204
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bays Harold¹,Dujovne Carlos²

Affiliation:

1. Medical Director/President, Louisville Metabolic and Atherosclerosis Research Center, 3288 Illinois Ave., Louisville KY, 40213, USA

2. Kansas Foundation for Clinical Pharmacology, Medical Director Radiant Research, Kansas City 12200 W 106th, Suite 330, Overland , Park KS 66215, USA. carlosdujovne@radiantresearch.com

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.11.9.1189

Reference76 articles.

1. Pounds of prevention: Obesity therapy

2. MORBIDITY OF SEVERE OBESITY

3. THE TREATMENT OF OBESITY IN TYPE 2 DIABETES MELLITUS

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist;Clinical Nutrition;2024-07

2. Simple Analysis of Lipid Inhibition Activity on an Adipocyte Micro-Cell Pattern Chip;Biomolecules;2018-06-04

3. Blood Pressure and its Association with Body Mass Index Among the People Attending in a Hospital;Journal of Nepal Medical Association;2017-12-31

4. Morinda citrifoliaL. leaf extract prevent weight gain in Sprague-Dawley rats fed a high fat diet;Food & Nutrition Research;2017-01

5. Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research;Current Topics in Medicinal Chemistry;2016-07-01